Labcorp Holdings Stock-Based Compensation 2010-2025 | LH

Labcorp Holdings stock-based compensation for the twelve months ending March 31, 2025 was $0.301B, a 8.5% decline year-over-year.

  • Labcorp Holdings annual stock-based compensation for 2024 was $0.117B, a 9.32% decline from 2023.
  • Labcorp Holdings annual stock-based compensation for 2023 was $0.129B, a 10.19% increase from 2022.
  • Labcorp Holdings annual stock-based compensation for 2022 was $0.117B, a 12.11% decline from 2021.

Labcorp Holdings Stock-Based Compensation 2010-2025 | LH

  • Labcorp Holdings annual stock-based compensation for 2024 was $0.117B, a 9.32% decline from 2023.
  • Labcorp Holdings annual stock-based compensation for 2023 was $0.129B, a 10.19% increase from 2022.
  • Labcorp Holdings annual stock-based compensation for 2022 was $0.117B, a 12.11% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$138.3B
CVS Health (CVS)$80.7B
Elevance Health (ELV)$77.8B
Cencora (COR)$57.7B
DiDi Global (DIDIY)$28.9B
Natera (NTRA)$20.3B
BioMerieux (BMXMF)$16.9B
EUROFINS SCIENT (ERFSF)$13.9B
CochLear (CHEOY)$12.8B
Solventum (SOLV)$12.6B
ICON (ICLR)$11.6B
Revvity (RVTY)$11.2B
Viatris (VTRS)$10.7B
Medpace Holdings (MEDP)$9B
Sonic Healthcare (SKHHY)$8.8B
Avantor (AVTR)$8.8B
HealthEquity (HQY)$8.4B
Caris Life Sciences,�Inc (CAI)$8B
Charles River Laboratories (CRL)$7.6B
Amplifon S.p.A (AMFPF)$5.4B
Bausch + Lomb (BLCO)$4.9B
BrightSpring Health Services (BTSG)$3.5B
Sotera Health (SHC)$3.2B
Surgery Partners (SGRY)$2.9B
Alignment Healthcare (ALHC)$2.6B
Concentras Parent (CON)$2.5B
Organon (OGN)$2.5B
GeneDx Holdings (WGS)$2.3B
Progyny (PGNY)$2B
PACS (PACS)$1.9B